Olema Pharmaceuticals, Inc. Quarterly Operating Lease, Payments in USD from Q1 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Olema Pharmaceuticals, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2022 to Q3 2024.
  • Olema Pharmaceuticals, Inc. Operating Lease, Payments for the quarter ending September 30, 2024 was $303K, a 3.81% decline year-over-year.
  • Olema Pharmaceuticals, Inc. Operating Lease, Payments for the twelve months ending September 30, 2024 was $1.12M, a 13.3% decline year-over-year.
  • Olema Pharmaceuticals, Inc. annual Operating Lease, Payments for 2023 was $1.23M, a 3.38% decline from 2022.
  • Olema Pharmaceuticals, Inc. annual Operating Lease, Payments for 2022 was $1.27M, a 28.9% increase from 2021.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $1.12M $303K -$12K -3.81% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $1.13M $293K -$34K -10.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $1.17M $260K -$66K -20.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $1.23M $263K -$60K -18.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-11
Q3 2023 $1.29M $315K -$4K -1.25% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $1.3M $327K +$10K +3.16% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $1.29M $326K +$11K +3.49% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $1.27M $323K Oct 1, 2022 Dec 31, 2022 10-K 2024-03-11
Q3 2022 $319K Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $317K Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $315K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.